Scarica l'app Stockscreener
10.45
0.76%
-0.08
Pre-mercato:
10.45
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché AHCO Giù?
Forum
Previsione
Precedente Chiudi:
$10.53
Aprire:
$10.53
Volume 24 ore:
730.70K
Relative Volume:
0.48
Capitalizzazione di mercato:
$1.42B
Reddito:
$3.24B
Utile/perdita netta:
$-66.64M
Rapporto P/E:
-19.69
EPS:
-0.5308
Flusso di cassa netto:
$219.38M
1 W Prestazione:
-1.97%
1M Prestazione:
-17.78%
6M Prestazione:
+8.97%
1 anno Prestazione:
+16.89%
Intervallo 1D:
$10.38
$10.57
Intervallo di 1 settimana:
$10.11
$11.03
Portata 52W:
$8.06
$13.43
Adapthealth Corp Stock (AHCO) Company Profile
Nome
Adapthealth Corp
Settore
Industria
Telefono
610-424-4515
Indirizzo
555 EAST NORTH LANE, CONSHOHOCKEN, PA
Compare AHCO vs ABT, SYK, MDT, BSX, EW
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
AHCO
Adapthealth Corp
|
10.45 | 1.43B | 3.24B | -66.64M | 219.38M | -0.5308 |
ABT
Abbott Laboratories
|
87.41 | 152.88B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
316.48 | 120.18B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
78.60 | 100.34B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
57.78 | 84.95B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
85.78 | 47.91B | 6.30B | 1.07B | 1.09B | 1.8406 |
Adapthealth Corp Stock (AHCO) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-01-08 | Downgrade | Jefferies | Buy → Hold |
| 2023-11-08 | Downgrade | BofA Securities | Neutral → Underperform |
| 2023-05-10 | Downgrade | Deutsche Bank | Buy → Hold |
| 2023-05-10 | Downgrade | Stifel | Buy → Hold |
| 2023-05-09 | Downgrade | BofA Securities | Buy → Neutral |
| 2021-09-27 | Iniziato | SVB Leerink | Outperform |
| 2021-07-14 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2021-04-13 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2021-03-18 | Iniziato | Truist | Buy |
| 2021-01-26 | Iniziato | BofA Securities | Buy |
| 2020-12-10 | Iniziato | UBS | Buy |
| 2020-08-10 | Iniziato | Canaccord Genuity | Buy |
| 2020-07-01 | Ripresa | SVB Leerink | Outperform |
| 2020-06-09 | Iniziato | RBC Capital Mkts | Outperform |
| 2020-01-31 | Iniziato | Stifel | Buy |
| 2020-01-07 | Iniziato | Jefferies | Buy |
| 2019-12-11 | Iniziato | SVB Leerink | Outperform |
| 2019-12-10 | Iniziato | Deutsche Bank | Buy |
Mostra tutto
Adapthealth Corp Borsa (AHCO) Ultime notizie
How Adapthealth Corp. (AHCO) Affects Rotational Strategy Timing - Stock Traders Daily
AHCO Stock Price, Quote & Chart | ADAPTHEALTH CORP (NASDAQ:AHCO) - ChartMill
What's Driving the Recent Buzz Around AdaptHealth (AHCO) - Kavout
Repligen, AdaptHealth, and IQVIA Stocks Trade Down, What You Need To Know - Yahoo Finance
AdaptHealth Corp.Common Stock (NQ: AHCO - The Chronicle-Journal
The Top 5 Analyst Questions From AdaptHealth’s Q1 Earnings Call - Yahoo Finance
Canaccord Lifts PT on AdaptHealth Corp. (AHCO) Following Q1 Results - Insider Monkey
Transcript : AdaptHealth Corp. Presents at Bank of America Global Healthcare Conference 2026, May-12-2026 09 - marketscreener.com
AdaptHealth Conference: Kaiser Deal Drives Growth, Labor Costs Dent EBITDA - MarketBeat
Senior Health, Home Health & Hospice Stocks Q1 Highlights: AdaptHealth (NASDAQ:AHCO) - Yahoo Finance
AdaptHealth's Labor Headwinds Lead to Fast Onboarding of Capitated Contract, RBC Says - marketscreener.com
AHCO Maintained by RBC Capital -- Price Target Raised to $15.00 - GuruFocus
(AHCO) and the Role of Price-Sensitive Allocations - Stock Traders Daily
AdaptHealth (AHCO) reports earnings tomorrow: What to expect - MSN
AdaptHealth Corp. (NASDAQ:AHCO) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
AdaptHealth Corp. 2026 Q1ResultsEarnings Call Presentation (NASDAQ:AHCO) 2026-05-09 - Seeking Alpha
A Look At AdaptHealth (AHCO) Valuation As Investor Interest And Price Targets Diverge - Yahoo Finance
AdaptHealth (AHCO) Boosts 2026 Outlook and Refinances Debt Is Its Growth Strategy Evolving? - Sahm
AHCO | AdaptHealth Corp. Common Stock FinancialsIncome Statement - Quiver Quantitative
AHCO Investor News: Rosen, Trusted National Trial Counsel, Encourages AdaptHealth Corp. f/k/a DFB Healthcare Acquisitions Corp. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class ActionAHCO, A - TMX Newsfile
Stocks making big moves yesterday: Cogent, AdaptHealth, BWX, IQVIA, and Palantir Technologies - StockStory
Deutsche Bank Adjusts AdaptHealth Price Target to $12 From $9.50, Maintains Hold Rating - marketscreener.com
AdaptHealth (AHCO) Q1 2026 Earnings Transcript - AOL.com
AdaptHealth Corp. (NASDAQ:AHCO) Q1 2026 Earnings Call Transcript - Insider Monkey
Why AdaptHealth (AHCO) shares are sliding today - MSN
AdaptHealth Q1 2026 slides: organic growth surges amid margin pressure By Investing.com - Investing.com Australia
About Us - FinancialContent
AHCO Q1 Deep Dive: Capitated Growth Boosts Revenue, Margin Pressures Persist - StockStory
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of AdaptHealth Corp. f/k/a DFB Healthcare Acquisitions Corp. of a Class Action Lawsuit and a Lead Plaintiff Deadline of September 27, 2021AHCO - TMX Newsfile
AdaptHealth Corp. Q1 2026 Earnings Call Summary - Yahoo Finance
[10-Q] AdaptHealth Corp. Quarterly Earnings Report - Stock Titan
AdaptHealth Corp. to Participate in Upcoming Investor Conferences - The Joplin Globe
AdaptHealth schedules two investor fireside chats in May, with webcasts - Stock Titan
Why AdaptHealth (AHCO) Shares Are Sliding Today - StockStory
AdaptHealth Q1 2026 slides: organic growth surges amid margin pressure - Investing.com
Earnings call transcript: AdaptHealth Q1 2026 results miss EPS, stock drops - Investing.com Nigeria
AdaptHealth Releases Q1 2026 Financial Results - AlphaStreet
AdaptHealth Q1 Earnings Call Highlights - Yahoo Finance
AdaptHealth sets stage for ‘defining year’ - HME News
AHCO: Record patient transition drove revenue above guidance, with margin set to improve as costs normalize - TradingView
Earnings call transcript: AdaptHealth Q1 2026 results miss EPS, stock drops By Investing.com - Investing.com South Africa
AdaptHealth : Q1 Financial document(0001628280 26 030120.htm) - marketscreener.com
AdaptHealth Corp. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
AdaptHealth Seeks Acquisitions - marketscreener.com
AHCO: Net revenue grew 5.4% year-over-year, but net loss and leverage increased in Q1 2026 - TradingView
AdaptHealth (NASDAQ:AHCO) Beats Q1 CY2026 Sales Expectations - TradingView
ADAPTHEALTH ($AHCO) Releases Q1 2026 Earnings - Quiver Quantitative
AdaptHealth falls on Q1 loss despite revenue beat By Investing.com - Investing.com Australia
AdaptHealth falls on Q1 loss despite revenue beat - Investing.com
Adapthealth Corp Azioni (AHCO) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Adapthealth Corp Azioni (AHCO) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| CASHIN RICHARD M JR | 10% Owner |
Mar 19 '26 |
Buy |
9.94 |
727 |
7,228 |
15,865,598 |
| Prast Albert A. | Chief Technology Officer |
Mar 13 '26 |
Option Exercise |
4.38 |
89,451 |
391,795 |
532,358 |
| CASHIN RICHARD M JR | 10% Owner |
Mar 10 '26 |
Buy |
9.73 |
820,528 |
7,982,671 |
14,638,708 |
| CASHIN RICHARD M JR | 10% Owner |
Mar 12 '26 |
Buy |
9.73 |
689,336 |
6,707,170 |
15,864,871 |
| CASHIN RICHARD M JR | 10% Owner |
Mar 11 '26 |
Buy |
9.73 |
536,827 |
5,222,307 |
15,175,535 |
| WOLF DALE B | Director |
Feb 27 '26 |
Buy |
8.96 |
8,000 |
71,680 |
104,235 |
| Rew Richard W. II | CLO and General Counsel |
Feb 26 '26 |
Buy |
8.91 |
5,000 |
44,550 |
107,097 |
| Williams David Solomon III | Director |
Dec 04 '25 |
Sale |
9.43 |
5,000 |
47,150 |
45,045 |
0.22%
1.41%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):